8086
Nipro Co., Ltd.
ニプロ株式会社
Precision Instruments
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company's Pharmaceutical-Related business engages in the contract manufacturing of pharmaceutical products with containers for combination products, including injectable kit products consigned by other pharmaceutical companies; and provides injectable, oral drugs products. In addition, its Pharma Packaging business offers pharmaceutical packaging containers and glass tubing, such as molded components for vials, syringes, rubber stoppers, and devices used to administer pharmaceuticals; and glass for thermos bottles, lighting and containers for combination products, glass equipment, as well glass for ampoules. Further, the company serves customers in Japan, the Americas, Europe, and rest of Asia. Nipro Corporation was founded in 1947 and is based in Settsu, Japan.
Price
¥1,721
Market Cap
¥281.7B
Ent. Value
¥744.2B
Net Debt
−¥462.5B
Shares Out.
163.7M
P / E
54.9×
EV / EBIT
28.0×
P / Book
1.11×
P / NCAV
N/M
Div. Yield
1.45%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥644.6B | ¥586.8B | ¥545.2B | ¥494.8B |
| Cost of Sales | ¥453.7B | ¥415.5B | ¥381.7B | ¥345.5B |
| Gross Profit | ¥190.9B | ¥171.3B | ¥163.4B | ¥149.3B |
| SG&A | ¥164.3B | ¥149.0B | ¥145.7B | ¥125.4B |
| Operating Income | ¥26.6B | ¥22.3B | ¥17.7B | ¥23.9B |
| Non-Operating Income | ¥5.5B | ¥8.9B | ¥7.3B | ¥10.5B |
| Dividend Income | ¥783M | ¥849M | ¥1.4B | ¥1.2B |
| Interest Income | ¥2.2B | ¥1.6B | ¥1.1B | ¥669M |
| Non-Operating Expenses | ¥21.3B | ¥11.8B | ¥9.7B | ¥6.8B |
| Interest Expense | ¥7.8B | ¥6.5B | ¥4.5B | ¥4.1B |
| Ordinary Income | ¥10.8B | ¥19.5B | ¥15.3B | ¥27.6B |
| Pre-tax Income | ¥19.1B | ¥19.2B | ¥16.8B | ¥23.2B |
| Income Taxes | ¥12.4B | ¥7.0B | ¥10.8B | ¥8.2B |
| Current Tax | ¥12.3B | ¥10.0B | ¥6.8B | ¥7.9B |
| Deferred Tax | ¥91M | ¥-3.0B | ¥4.1B | ¥308M |
| Net Income (owners) | ¥5.1B | ¥11.1B | ¥4.6B | ¥13.5B |
| Minority Interest | ¥1.6B | ¥1.1B | ¥1.4B | ¥1.6B |
| Comprehensive Income | ¥26.3B | ¥29.9B | ¥26.0B | ¥32.0B |
| EBITDA | ¥92.2B | ¥81.2B | ¥66.5B | ¥70.0B |
| Goodwill Amort. (J-GAAP) | ¥3.1B | ¥2.8B | ¥2.5B | ¥2.9B |
| EPS | ¥31.36 | ¥68.12 | ¥28.05 | ¥82.50 |
| Shares Outstanding | 163.7M | 163.7M | 163.7M | 163.7M |
| Shares Issued (total) | 171.5M | 171.5M | 171.5M | 171.5M |
| Treasury Shares | 7.8M | 7.8M | 7.8M | 7.8M |
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | ¥1,170.6B | ¥1,109.8B | ¥1,027.4B | ¥930.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Assets | ¥574.4B | ¥524.2B | ¥489.3B | ¥437.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Deposits | ¥106.7B | ¥99.7B | ¥89.7B | ¥95.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade Receivables | ¥148.8B | ¥139.3B | ¥141.7B | ¥121.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Assets | ¥596.1B | ¥585.7B | ¥538.1B | ¥492.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PP&E | ¥503.8B | ¥481.5B | ¥432.6B | ¥377.8B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill | ¥14.1B | ¥15.6B | ¥14.5B | ¥15.1B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets | ¥35.5B | ¥35.1B | ¥34.0B | ¥32.8B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment Securities | ¥15.3B | ¥32.9B | ¥37.2B | ¥45.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Assets | ¥17.2B | ¥13.1B | ¥10.4B | ¥12.4B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ¥858.9B | ¥840.0B | ¥785.2B | ¥730.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Liabilities | ¥350.5B | ¥366.5B | ¥302.9B | ¥312.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Payable | ¥83.8B | ¥81.5B | ¥76.1B | ¥73.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ST Debt | ¥156.2B | ¥160.4B | ¥130.6B | ¥150.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taxes Payable | ¥5.9B | ¥6.1B | ¥4.9B | ¥5.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Liabilities | ¥508.4B | ¥473.6B | ¥482.3B | ¥418.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total LT Borrowings | ¥413.0B | ¥384.8B | ¥393.3B | ¥346.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pension Obligations | ¥7.2B | ¥5.7B | ¥5.2B | ¥5.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Liab. | ¥2.0B | ¥1.6B | ¥1.3B | ¥617M | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | ¥311.6B | ¥269.8B | ¥242.2B | ¥199.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Stock | ¥84.4B | ¥84.4B | ¥84.4B | ¥84.4B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Surplus | — | ¥0M | — | — | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retained Earnings | ¥104.8B | ¥104.3B | ¥95.5B | ¥94.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury Stock | ¥-10.7B | ¥-10.7B | ¥-10.7B | ¥-10.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AOCI | ¥74.0B | ¥54.7B | ¥37.1B | ¥16.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity (owners) | ¥178.4B | ¥178.0B | ¥169.2B | ¥168.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Minority Interests | ¥59.2B | ¥37.1B | ¥35.9B | ¥14.6B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Interest-Bearing Debt ⓘ | ¥569.2B | ¥545.2B | ¥523.8B | ¥497.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Cash ⓘ | ¥-462.5B | ¥-445.5B | ¥-434.1B | ¥-401.6B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV ⓘ | ¥-284.5B | ¥-315.9B | ¥-295.9B | ¥-293.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV/Share | ¥-1,738 | ¥-1,930 | ¥-1,808 | ¥-1,790 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BV/Share | ¥1,090 | ¥1,087 | ¥1,033 | ¥1,028 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Operating CF | ¥68.5B | ¥72.9B | ¥10.4B | ¥68.2B |
| Interest Paid | ¥-7.8B | ¥-6.3B | ¥-4.3B | ¥-4.0B |
| Interest Received | ¥3.0B | ¥2.3B | ¥2.3B | ¥1.9B |
| D&A | ¥62.5B | ¥56.0B | ¥46.3B | ¥43.3B |
| Goodwill Amort. | ¥3.1B | ¥2.8B | ¥2.5B | ¥2.9B |
| Investing CF | ¥-71.9B | ¥-87.1B | ¥-71.7B | ¥-78.4B |
| Purchase Investments | ¥-351M | ¥-463M | ¥-51M | ¥-253M |
| Proceeds from Invest. | ¥13.7B | ¥8.6B | ¥5.0B | ¥262M |
| Financing CF | ¥5.4B | ¥22.1B | ¥43.1B | ¥10.3B |
| Dividends Paid | ¥-4.4B | ¥-3.0B | ¥-4.2B | ¥-5.2B |
| Share Buybacks | ¥-7M | ¥-34M | ¥-1M | ¥-2M |
| LT Debt Repaid | ¥-90.4B | ¥-65.5B | ¥-75.0B | ¥-100.8B |
| Free Cash Flow | ¥68.5B | ¥72.9B | ¥10.4B | ¥68.2B |
| Net Change in Cash | ¥5.0B | ¥11.9B | ¥-5.4B | ¥4.2B |
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| ROE | 2.1% | 5.1% | 2.3% | 7.8% |
| ROA | 0.4% | 1.0% | 0.5% | 1.4% |
| EPS | ¥31.36 | ¥68.12 | ¥28.05 | ¥82.50 |
| DPS | ¥25.00 | ¥25.00 | ¥22.00 | ¥27.00 |
| BPS | ¥1,547.82 | ¥1,426.56 | ¥1,265.00 | ¥1,135.76 |
| FCF/Share | ¥418 | ¥446 | ¥64 | ¥417 |
| NCAV/Share | ¥-1,738 | ¥-1,930 | ¥-1,808 | ¥-1,790 |
| Payout Ratio | 79.7% | 36.7% | 78.4% | 32.7% |
Event Timeline
S Shareholder
A Capital Signal
Large Shareholder Reports 40
Capital Allocation Signals 1
| Date | Type | Amount | Summary | |
|---|---|---|---|---|
|
2026-05-12
15:30
|
Div Increase | ¥3.1B ¥19.0/sh +46% | Nipro Corporation's board resolved on May 12, 2026 to pay a dividend of ¥19.00 per share (record date March 31, 2026) to… | |
|
Summary
Nipro Corporation's board resolved on May 12, 2026 to pay a dividend of ¥19.00 per share (record date March 31, 2026) totaling ¥3,110 million, representing a ¥1.00 increase from the prior forecast of ¥18.00. This represents a 46.2% increase year-over-year from ¥13.00 in the prior fiscal year (FY2025), reflecting the company's dividend policy of distributing 35% of consolidated net income while maintaining a ¥25 minimum annual dividend floor.
YoY: +46%
Source (JP)
当期の期末配当金につきましては、上記方針に基づき、直近の配当予想に比較し1株あたり 1 円の増配となる、1株あたり 19 円とすることといたしました。
剰余金の配当に関するお知らせ
TDnet PDF
|
||||
| # | Shareholder | Shares (thou.) | % of Total |
|---|---|---|---|
| 1 |
Japan Master Trust Bank
日本マスタートラスト信託銀行株式会社(信託口)
|
19,469 | 11.89% |
| 2 |
Nippon Electric Glass Co., Ltd.
日本電気硝子株式会社
|
11,576 | 7.07% |
| 3 |
Japan Custody Bank
株式会社日本カストディ銀行(信託口)
|
8,419 | 5.14% |
| 4 |
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)
BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC)(常任代理人 株式会社三菱UFJ銀行)
|
6,637 | 4.05% |
| 5 | JPモルガン証券株式会社 | 4,354 | 2.66% |
| 6 | BNYMSANV RE GCLB RE JP RD LMGC(常任代理人 シティバンク、エヌ・エイ東京支店) | 3,789 | 2.31% |
| 7 | NOMURA PB NOMINEES LIMITED OMNIBUS-MARGIN (CASHPB)(常任代理人 野村證券株式会社) | 3,781 | 2.31% |
| 8 | HSBC HONG KONG-TREASURY SERVICES A/C ASIAN EQUITIES DERIVATIVES(常任代理人 香港上海銀行東京支店カストディ業務部) | 3,501 | 2.14% |
| 9 | BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE(常任代理人 株式会社三菱UFJ銀行) | 2,798 | 1.71% |
| 10 | モルガン・スタンレーMUFG証券株式会社 | 2,761 | 1.69% |
as of 2025-03-31
Source: EDINET ↗
Ownership by year — hover bars for detail
Domestic Nominees
17.0%
-1.5% vs 2024
Trust bank custodians — GPIF, pensions, investment trusts
Foreign Custodians
0.0%
+0.0% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
23.9%
+3.9% vs 2024
Named entities with disclosed investment intent
Bar = % of shares outstanding · top-10 covers 41.0% · grey = other shareholders · 2025
| Shareholder | Trend | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Japan Master Trust Bank 日本マスタートラスト信託銀行 | 13.21% | 12.39% | 11.89% -0.50% | |
| Nippon Electric Glass Co., Ltd. 日本電気硝子 | 10.47% | 8.34% | 7.07% -1.27% | |
| Japan Custody Bank 日本カストディ銀行 | 6.00% | 6.18% | 5.14% -1.04% | |
| BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC) BNY GCM CLIENT ACCOUNT JPRD AC ISG (FE-AC) | — | 2.46% | 4.05% +1.59% | |
| JPモルガン証券 NEW ENTRY | — | — | — | 2.66% NEW |
| NOMURA PB NOMINEES LIMITED OMNIBUS-MARGIN (CASHPB) NEW ENTRY | — | — | — | 2.31% NEW |
| BNYMSANV RE GCLB RE JP RD LMGC NEW ENTRY | — | — | — | 2.31% NEW |
| HSBC HONG KONG-TREASURY SERVICES A/C ASIAN EQUITIES DERIVATIVES NEW ENTRY | — | — | — | 2.14% NEW |
| BNYM SA/NV FOR BNYM FOR BNYM GCM CLIENT ACCTS M ILM FE NEW ENTRY | — | — | — | 1.71% NEW |
| Morgan Stanley NEW ENTRY | — | — | — | 1.69% NEW |
| JP MORGAN CHASE BANK JP MORGAN CHASE BANK 385632 last seen 2024 | Exited Top 10 | 2.78% | 2.72% | — |
| Employee Stock Ownership Plan ニプロ従業員持株会 last seen 2024 | Exited Top 10 | 1.59% | 1.61% | — |
| MLI FOR CLIENT GENERAL OMNI NON COLLATERAL NON TREATY-PB MLI FOR CLIENT GENERAL OMNI NON COLLATERAL NON TREATY-PB last seen 2024 | Exited Top 10 | — | 1.53% | — |
| STATE STREET BANK AND TRUST COMPANY STATE STREET BANK AND TRUST COMPANY 505223 last seen 2024 | Exited Top 10 | 0.63% | 1.22% | — |
| 佐 野 和 美 last seen 2024 | Exited Top 10 | 1.17% | 1.17% | — |
| STATE STREET BANK WEST CLIENT-TREATY STATE STREET BANK WEST CLIENT-TREATY 505234 last seen 2024 | Exited Top 10 | — | 1.01% | — |
| STATE STREET BANK WEST CLIENT -TREATY 505234 last seen 2023 | Exited Top 10 | 1.07% | — | — |
| SSBTC CLIENT OMNIBUS ACCOUNT last seen 2023 | Exited Top 10 | 0.60% | — | — |
| りそな銀行 last seen 2023 | Exited Top 10 | 1.91% | — | — |
| Concentration (HHI) ⓘ | 337 | 284 | 262 |
3 fiscal years · top-10 holders per year · >2,500 HHI = high concentration · entity-resolved
Portfolio Book Value
¥7,448M
-68% since 2023
Holdings
20
+1 new
2 exited
Trend
1 unwinding
vs 2023
| Held Company | FY2025 ¥7,448M total | FY2023 ¥23,159M total | |||
|---|---|---|---|---|---|
| Book Val ¥M | Shares | Book Val ¥M | Shares | ||
|
Nippon Electric Glass Co., Ltd.
日本電気硝子㈱
|
4,375 |
-84.1%
↓
1,254,920
|
20,129 | 7,897,020 | M |
|
YUKI GOSEI KOGYO CO.,LTD.
有機合成薬品工業㈱
|
873 |
3,296,300
|
979 | 3,296,300 | M |
|
ZOJIRUSHI CORPORATION
象印マホービン㈱
|
543 |
363,000
|
578 | 363,000 | M |
|
SHIBUYA CORPORATION
澁谷工業㈱
|
480 |
150,000
|
374 | 150,000 | M |
|
KIMURA CHEMICAL PLANTS CO., LTD.
木村化工機㈱
|
291 |
400,000
|
271 | 400,000 | M |
|
Rengo Co., Ltd.
レンゴー㈱
|
285 |
360,000
|
309 | 360,000 | M |
|
Growth X Partners, Inc.
グロースエクスパートナーズ㈱
|
209 |
NEW
New
130,000
|
— | M | |
|
MORITA HOLDINGS CORPORATION
㈱モリタホールディングス
|
124 |
60,000
|
79 | 60,000 | M |
|
MEDIPAL HOLDINGS CORPORATION
㈱メディパルホールディングス
|
103 |
44,500
|
80 | 44,500 | M |
|
Quall Holdings Co., Ltd.
クオールホールディングス㈱
|
78 |
43,600
|
50 | 43,600 | M |
|
Aichi Financial Group Co., Ltd.
㈱あいちフィナンシャルグループ
|
62 |
21,794
|
46 | 21,794 | |
|
Wakamoto Pharmaceutical Co., Ltd.
わかもと製薬㈱
|
10 |
+4.6%
↑
34,300
|
8 | 32,793 | M |
| 第一生命ホールディングス㈱ | 9 |
+300.0%
↑
8,400
|
5 | 2,100 | |
|
Mizuho Financial Group, Inc.
㈱みずほフィナンシャルグループ
|
6 |
1,661
|
3 | 1,661 | |
| ㈱愛知銀行 | — | — | M | ||
| ㈱三菱ケミカルホールディングス | — | — | |||
| ㈱三菱UFJフィナンシャルグループ | — | — | |||
|
TOHO HOLDINGS CO.,LTD.
東邦ホールディングス㈱
|
— | — | M | ||
| ㈱バイタルケーエスケーホールディングス | — | — | |||
|
HISAMITSU PHARMACEUTICAL CO.,INC.
久光製薬㈱
|
— | — | |||
| TC BioPharm | — |
−100%
Exit
—
|
8 | 38,610 | |
|
Resona Holdings, Inc.
㈱りそなホールディングス
|
— |
−100%
Exit
—
|
240 | 375,992 | |
| Portfolio total | 7,448 | 23,159 | |||
Book value in ¥M · ↓ reduced · ↑ increased vs prior year · M = mutual holding